PVT1 and neoplasm: Since MYC depends on PVT1 in its ability to drive malignant transformation and is itself difficult to target because it lacks enzymatic activity, several groups have speculated about the validity and feasibility to target PVT1 to weaken or inhibit MYC in tumor cells.